Agilent Technologies Inc. reported third-quarter adjusted earnings per share of $1.62, exceeding the $1.49 consensus estimate, as revenue climbed 8.1% year-over-year to $1.88 billion.
The company’s Life Sciences and Diagnostics Markets Group led segment growth with an 11% increase, generating $746 million in revenue. Adjusted operating margin expanded by 320 basis points to 28.3%, including a 110 basis-point benefit from tariff refunds.
Agilent raised its full-year fiscal 2026 adjusted EPS guidance to a range of $6.18 to $6.21, up from prior expectations. Revenue guidance was increased to $7.49 billion to $7.51 billion, representing growth of 7.8% to 8.1% versus the prior outlook. Fourth-quarter revenue is expected to reach $1.98 billion to $2.0 billion, while adjusted EPS is projected at $1.71 to $1.74.
Shares rose 3% in after-hours trading following the results. CEO Padraig McDonnell attributed the performance to sustained momentum from the company’s strategy and the Ignite Operating System, citing improving end markets and strong demand in key regions.
